Cefazolin vs cloxacillin in MSSA endocarditis : too good to be true?
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:142 |
|---|---|
| Enthalten in: |
International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases - 142(2024) vom: 15. Apr., Seite 106978 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Buis, David Tijmen Paulus [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Anti-Bacterial Agents |
|---|
| Anmerkungen: |
Date Completed 16.04.2024 Date Revised 16.04.2024 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.ijid.2024.02.021 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM368917568 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM368917568 | ||
| 003 | DE-627 | ||
| 005 | 20240416232606.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240229s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.ijid.2024.02.021 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1377.xml |
| 035 | |a (DE-627)NLM368917568 | ||
| 035 | |a (NLM)38401781 | ||
| 035 | |a (PII)S1201-9712(24)00049-3 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Buis, David Tijmen Paulus |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Cefazolin vs cloxacillin in MSSA endocarditis |b too good to be true? |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 16.04.2024 | ||
| 500 | |a Date Revised 16.04.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Letter | |
| 650 | 4 | |a Cefazolin | |
| 650 | 4 | |a Clinical epidemiology | |
| 650 | 4 | |a Endocarditis | |
| 650 | 4 | |a MSSA | |
| 650 | 7 | |a Cefazolin |2 NLM | |
| 650 | 7 | |a IHS69L0Y4T |2 NLM | |
| 650 | 7 | |a Cloxacillin |2 NLM | |
| 650 | 7 | |a O6X5QGC2VB |2 NLM | |
| 650 | 7 | |a Anti-Bacterial Agents |2 NLM | |
| 773 | 0 | 8 | |i Enthalten in |t International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases |d 1998 |g 142(2024) vom: 15. Apr., Seite 106978 |w (DE-627)NLM094730857 |x 1878-3511 |7 nnns |
| 773 | 1 | 8 | |g volume:142 |g year:2024 |g day:15 |g month:04 |g pages:106978 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.ijid.2024.02.021 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 142 |j 2024 |b 15 |c 04 |h 106978 | ||